干燥设备 粉碎设备 混合设备 反应设备 过滤分离设备 过滤材料 灭菌设备 萃取设备 贮存设备 传热设备 锅炉 塔设备 结晶设备 其他制药设备
台州市科瑞生物技术有限公司
CAS号 | 170277-31-3 | 产地 | 国产 |
---|---|---|---|
分子式 | C6428H9912N1694O1987S46 | 级别 | 医用级 |
Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. Infliximab was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.It is used off-label outside its FDA approval for Behçet's disease and other conditions. Infliximab is administered by intravenous infusion, typically at six- to eight-week intervals. It cannot be given by mouth because the digestive system would destroy the drug.
英夫利昔单抗是一种嵌合单克隆抗体生物学药物不利于肿瘤坏死因子-α (tumor necrosis factor-α,TNF-α) 用于治疗自身免疫性疾病.英夫利昔单抗经美国食品和药物管理局 (FDA) 治疗克罗恩病,溃疡性结肠炎,牛皮癣,银屑病关节炎、强直性脊柱炎、类风湿关节炎.它是用于适应症外 FDA 批准白塞病等情况.英夫利昔单抗是通过静脉内输注,通常在六到八周的间隔.它不能口服因为消化系统会摧毁.
您感兴趣的产品PRODUCTS YOU ARE INTERESTED IN
制药网 设计制作,未经允许翻录必究 .
请输入账号
请输入密码
请输验证码
请输入你感兴趣的产品
请简单描述您的需求
请选择省份